Insulin sensitivity at childhood predicts changes in total and central adiposity over a 6-year period

I Labayen1, J R Ruiz, F B Ortega

  • 1Department of Nutrition and Food Science, University of the Basque Country, Paseo de la Universidad, 7, Vitoria, Spain. idoia.labayen@ehu.es

Insights

Childhood insulin resistance predicts increased adiposity in adolescence. Lower insulin sensitivity in youth may lead to greater body fat and waist circumference gain by age 15, highlighting its role in obesity prevention.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Health
  • Obesity Research

Background:

  • Insulin resistance in childhood is a growing concern with potential long-term health implications.
  • Understanding early predictors of adiposity is crucial for effective obesity prevention strategies.
  • The European Youth Heart Study provides a valuable cohort for investigating childhood metabolic health.

Purpose of the Study:

  • To investigate the association between childhood insulin resistance and subsequent changes in adiposity over a six-year period.
  • To determine if early markers of insulin resistance predict adolescent body composition.
  • To explore the predictive value of insulin sensitivity for total and central adiposity gain.

Main Methods:

  • Longitudinal study of 659 children (ages 9-15) from Sweden and Estonia.
  • Measurements included weight, height, skinfolds, waist circumference, and calculated BMI, sum of skinfolds, and body fat percentage.
  • Fasting glucose and insulin were measured to calculate homeostasis model assessment of insulin resistance (HOMA-IR); puberty stage, sex, and center were used as confounders.

Main Results:

  • Childhood HOMA-IR was significantly associated with increased BMI, sum of skinfolds, body fat percentage, and waist circumference from age 9 to 15.
  • These associations remained significant even after excluding overweight children.
  • Childhood adiposity measures did not predict changes in HOMA-IR over the study period.

Conclusions:

  • Lower insulin sensitivity in childhood is a significant predictor of increased total and central adiposity during adolescence.
  • These findings underscore the importance of targeting insulin sensitivity for early obesity prevention efforts.
  • Interventions aimed at improving insulin sensitivity in early life may mitigate adolescent adiposity gain.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...